InnoCare Pharma innocarepharma.com


Public lists: Pharma Startups (6570)

InnoCare Pharma (09969.HK) is developing multiple candidate products that are designed to modulate the immune system in order to treat autoimmune disease and cancers. Its products are intended to be used independently or in combination with other immune-therapies.

InnoCare Pharma (09969.HK) is developing multiple candidate products that are designed to modulate the immune system in order to treat autoimmune disease and cancers. Its products are intended to be used independently or in combination with other imm...Show all

Company (IPO / Went public)

Phone: +86 10 66609999

Fax:

Building 8, No. 8 Life Science Park Road
Zhongguancun Life Science Park, Changping District
Beijing, 100084
Beijing, China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
InnoCare Pharma $215M Mar 20, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related InnoCare Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Substituted nicotinamide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease Sep 29, 2014 Apr 24, 2018 Patent